| 1. |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2):87-108.
|
| 2. |
赫捷, 陈万青. 2012中国肿瘤登记年报. 军事医学科学出版社, 2012:64-67, 194-195.
|
| 3. |
NCCN Clinical Practice Guidelines in Oncology Version. 2015. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
|
| 4. |
Mansour JC, Aloia TA, Crane CH, et al. Hilar cholangiocarcinoma:expert consensus statement. HPB (Oxford), 2015, 17(8):691-699.
|
| 5. |
Benavides M, Antón A, Gallego J, et al. Biliary tract cancers:SEOM clinical guidelines. Clin Transl Oncol, 2015, 17(12):982-987.
|
| 6. |
European Association for the Study of the Liver. EASL Clinical Prac-tice Guidelines:Liver transplantation. J Hepatol, 2016, 64(2):433-485.
|
| 7. |
Khan SA, Davidson BR, Goldin RD, et al. British Society of Gastro-enterology. Guidelines for the diagnosis and treatment of cholangio-carcinoma:an update. Gut, 2012, 61(12):1657-1669.
|
| 8. |
Eckel F, Brunner T, Jelic S. ESMO Guidelines Working Group. Biliary cancer:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2011, 22 Suppl 6:vi40-vi44.
|
| 9. |
Miyazaki M, Yoshitomi H, Miyakawa S, et al. Clinical practice guidelines for the management of biliary tract cancers 2015. the 2nd English edition. J Hepatobiliary Pancreat Sci, 2015, 22(4):249-273.
|
| 10. |
Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific Working Group on Hepatobiliary Cancers. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol, 2013, 28(4):593-607.
|
| 11. |
中国抗癌协会. 肝门部胆管癌规范化诊治专家共识(2015). 中华肝胆外科杂志, 2015, 21(8):505-511.
|
| 12. |
中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断和治疗指南(2013版). 中华外科杂志, 2013, 51(10):865-871.
|
| 13. |
Charbel H, Al-Kawas FH. Cholangiocarcinoma:epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep, 2011, 3(2):182-187.
|
| 14. |
Chen P, Li B, Zhu Y, et al. Establishment and validation of a progno-stic nomogram for patients with resectable perihilar cholangiocar-cinoma. Oncotarget, 2016, 7(24):37319-37330.
|
| 15. |
Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg, 1992, 15(1):31-38.
|
| 16. |
Gazzaniga GM, Faggioni A, Filauro M. Surgical treatment of proximal bile duct tumors. Int Surg, 1985, 70(1):45-48.
|
| 17. |
Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 25 patients with hilar cholangiocarcinoma. Ann Surg, 2001, 34(4):507-517.
|
| 18. |
American Joint Committee on Cancer. UICC/AJCC stage grouping. 7th edition. 2009. http://www.cancerstaging.org.
|
| 19. |
Deoliveira ML, Schulick RD, Nimura Y, et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology, 2011, 53(4):1363-1371.
|
| 20. |
Chaiteerakij R, Harmsen WS, Marrero CR, et al. A new clinically based staging system for perihilar cholangiocarcinoma. Am J Gastroenterol, 2014, 109(12):1881-1890.
|
| 21. |
Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic naso-biliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma:a retrospective study of efficacy and risk factors related to complications. Ann Surg, 2013, 257(1):121-127.
|
| 22. |
姜小清, 易滨, 吴孟超, 等. 肝门部胆管癌10年外科治疗经验. 中华消化外科杂志, 2010, 9(3):180-182.
|
| 23. |
易滨, 姜小清. 肝门部胆管癌的计划性肝切除. 中国普外基础与临床杂志, 2011, 18(6):576-578.
|
| 24. |
张蜀豫, 马兴涛, 姜小清, 等. 肝门部胆管癌患者术前口服胆汁的疗效研究. 肿瘤代谢与营养电子杂志, 2015, 2(2):48-51.
|
| 25. |
Friman S, Foss A, Isoniemi H, et al. Liver transplantation for cholan-giocarcinoma:selection is essential for acceptable results. Scand J Gastroenterol, 2011, 46(3):370-375.
|
| 26. |
Croome KP, Rosen CB, Heimbach JK, et al. Is liver transplantation appropriate for patients with potentially resectable de novo hilar cholangiocarcinoma? J Am Coll Surg, 2015, 221(1):130-139.
|
| 27. |
Todoroki T, Ohara K, Kawamoto T, et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys, 2000, 46(3):581-587.
|
| 28. |
Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer:improved survival after photodynamic therapy. Am J Gastroenterol, 2005, 100(11):2426-2430.
|
| 29. |
Cheon YK, Cho YD, Baek SH, et al. Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus photodynamic therapy with external drainage. Korean J Gastroenterol, 2004, 44(5):280-287.
|
1/5
WeChat